MARKET

DYAI

DYAI

Dyadic Intl Inc Del
NASDAQ
1.470
+0.260
+21.49%
After Hours: 1.520 +0.05 +3.40% 17:15 07/21 EDT
OPEN
1.220
PREV CLOSE
1.210
HIGH
1.550
LOW
1.200
VOLUME
717.20K
TURNOVER
--
52 WEEK HIGH
1.550
52 WEEK LOW
0.6546
MARKET CAP
53.56M
P/E (TTM)
-6.4276
1D
5D
1M
3M
1Y
5Y
1D
12 Health Care Stocks Moving In Tuesday's Intraday Session
Benzinga · 5h ago
Weekly Report: what happened at DYAI last week (0713-0717)?
Weekly Report · 1d ago
Wall Street Analysts Are Bullish on Top Healthcare Picks
TipRanks · 1d ago
Dyadic expands bio-industrial pipeline with new industrial enzyme program
TipRanks · 5d ago
DYADIC INTERNATIONAL - TO PURSUE COMMERCIALIZATION THROUGH SALES, COLLABORATIONS, MANUFACTURING, AND LICENSING
Reuters · 5d ago
DYADIC INTERNATIONAL - TO PURSUE MULTIPLE COMMERCIALIZATION PATHWAYS FOR NEW ENZYME PROGRAM
Reuters · 5d ago
Top Biotech Gainers: NXTC Soars On Merger Deal, BMGL Moves Past Nasdaq Woes, OTLK Awaits FDA Verdict
NASDAQ · 6d ago
Weekly Report: what happened at DYAI last week (0706-0710)?
Weekly Report · 07/13 09:03
More
About DYAI
Dyadic International, Inc. is a biotechnology company focused on the large-scale manufacture of proteins for use in human and animal vaccines and therapeutics and for use in non-pharmaceutical applications including food, nutrition, and wellness. The Company's gene expression and protein production platforms are based on the highly productive and scalable fungus Thermothelomyces heterothallica, which the Company named C1. The Compny’s lead technology, C1-cell protein production platform, is based on an industrially proven microorganism (named C1), which is used to speed development and improve performance of biologic vaccines and drugs at flexible commercial scales for the human and animal health markets. The Company has also developed the Dapibus filamentous fungal based microbial protein production platform to enable the rapid development and large-scale manufacture of low-cost proteins, metabolites, and other biologic products for use in non-pharmaceutical applications.

Webull offers Dyadic International Inc stock information, including NASDAQ: DYAI real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, DYAI stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading DYAI stock methods without spending real money on the virtual paper trading platform.